InBody CoLtd (Korea) Performance
| 041830 Stock | KRW 23,800 600.00 2.59% |
The company owns a Beta (Systematic Risk) of -0.089, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning InBody CoLtd are expected to decrease at a much lower rate. During the bear market, InBody CoLtd is likely to outperform the market. InBody CoLtd presently owns a risk of 2.05%. Please check out InBody CoLtd market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to decide if InBody CoLtd will be following its current price history.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days InBody CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, InBody CoLtd is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -25.1 B |
InBody |
InBody CoLtd Relative Risk vs. Return Landscape
If you would invest 2,400,000 in InBody CoLtd on October 5, 2024 and sell it today you would lose (20,000) from holding InBody CoLtd or give up 0.83% of portfolio value over 90 days. InBody CoLtd is generating 0.007% of daily returns and assumes 2.0537% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than InBody, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
InBody CoLtd Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for InBody CoLtd's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as InBody CoLtd, and traders can use it to determine the average amount a InBody CoLtd's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0034
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 041830 |
Estimated Market Risk
| 2.05 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average InBody CoLtd is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of InBody CoLtd by adding InBody CoLtd to a well-diversified portfolio.
InBody CoLtd Fundamentals Growth
InBody Stock prices reflect investors' perceptions of the future prospects and financial health of InBody CoLtd, and InBody CoLtd fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on InBody Stock performance.
| Return On Equity | 18.84 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 331.29 B | |||
| Shares Outstanding | 13.48 M | |||
| Price To Earning | 30.89 X | |||
| Price To Sales | 2.02 X | |||
| Revenue | 137.84 B | |||
| EBITDA | 37.57 B | |||
| Cash And Equivalents | 18.56 B | |||
| Total Debt | 1.83 B | |||
| Cash Flow From Operations | 30.35 B | |||
| Total Asset | 203.76 B | |||
| Retained Earnings | 73.14 B | |||
| Current Asset | 64.45 B | |||
| Current Liabilities | 11.26 B | |||
About InBody CoLtd Performance
By analyzing InBody CoLtd's fundamental ratios, stakeholders can gain valuable insights into InBody CoLtd's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if InBody CoLtd has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if InBody CoLtd has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
InBody Co., Ltd. provides body composition analysis solutions worldwide. InBody Co., Ltd. was founded in 1996 and is based in Mumbai, India. InBody is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about InBody CoLtd performance evaluation
Checking the ongoing alerts about InBody CoLtd for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for InBody CoLtd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 29.0% of the company shares are owned by insiders or employees |
- Analyzing InBody CoLtd's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether InBody CoLtd's stock is overvalued or undervalued compared to its peers.
- Examining InBody CoLtd's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating InBody CoLtd's management team can have a significant impact on its success or failure. Reviewing the track record and experience of InBody CoLtd's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of InBody CoLtd's stock. These opinions can provide insight into InBody CoLtd's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for InBody Stock analysis
When running InBody CoLtd's price analysis, check to measure InBody CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InBody CoLtd is operating at the current time. Most of InBody CoLtd's value examination focuses on studying past and present price action to predict the probability of InBody CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InBody CoLtd's price. Additionally, you may evaluate how the addition of InBody CoLtd to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |